Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
The new Clinical Practice Guidelines of Cardio-Oncology were released in August 2022. RESILIENCE is proud to count with two relevant members of the Task Force as project investigators. Teresa López-Fernández is the Chairperson of this Clinical Practice Guideline and co-Principal investigator of European Society of Cardiology (ESC) in RESILIENCE project. Raúl Córdoba is the Principal […]
